Delivery Order SPE2DB20D1100-SPE2DB24FC2A7

Award Date 6/10/24
Potential Completion Date 6/11/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FWG33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,448.56 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET medication, with a period of performance through July 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,170.66 firm-fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
The federal contract award, SPE2DB22D2009|SPE2DB25FL8FS, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,166.58 Firm Fixed Price Delivery Order contract is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. AmerisourceBergen holds a...
This federal contract award, with ID SPE2DB24D2205|SPE2DB24FEAHE, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $52,037.71 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. This contract has a completion date of September 24, 2024 and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,055.16 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty medication. The contract has an ultimate completion date of February 25, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FA0J2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,099.71, is a Firm Fixed Price Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a medical product. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen Drug Corp is the prime contractor for this...
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAJ96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,595.56 Firm Fixed Price Delivery Order contract is for the provision of BIKTARVY 50-200-25 MG TABLET medical products. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $10,773.73 delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $13,705.89, is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of November 28, 2023 and is a Firm Fixed Price type contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTYW1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,828.36 firm fixed-price delivery order contract is for the BIKTARVY 50-200-25 MG TABLET, with an ultimate completion date of December 19, 2024. The contract is not designated with a set-aside requirement, indicating open competition. As a large pharmaceutical distributor,...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC2A7
    Delivery Order

This federal contract award, with an ID of SPE2DB20D1100|SPE2DB24FC2A7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,143.90, is a Firm Fixed Price Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30 tablets. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 11:50 AM